nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—urine—polycystic ovary syndrome	0.0372	0.0995	CbGeAlD
Dorzolamide—CA5A—endocrine gland—polycystic ovary syndrome	0.0328	0.0879	CbGeAlD
Dorzolamide—CYP3A4—urine—polycystic ovary syndrome	0.0284	0.0759	CbGeAlD
Dorzolamide—CA14—adrenal gland—polycystic ovary syndrome	0.021	0.0562	CbGeAlD
Dorzolamide—CA9—endocrine gland—polycystic ovary syndrome	0.0192	0.0513	CbGeAlD
Dorzolamide—CA5B—adipose tissue—polycystic ovary syndrome	0.0164	0.0438	CbGeAlD
Dorzolamide—CA5B—adrenal gland—polycystic ovary syndrome	0.0147	0.0393	CbGeAlD
Dorzolamide—CA1—adipose tissue—polycystic ovary syndrome	0.0145	0.0387	CbGeAlD
Dorzolamide—CA2—embryo—polycystic ovary syndrome	0.0142	0.038	CbGeAlD
Dorzolamide—CA12—endocrine gland—polycystic ovary syndrome	0.0142	0.038	CbGeAlD
Dorzolamide—CA5B—vagina—polycystic ovary syndrome	0.0136	0.0364	CbGeAlD
Dorzolamide—CA5B—endocrine gland—polycystic ovary syndrome	0.0127	0.0341	CbGeAlD
Dorzolamide—CA2—adrenal cortex—polycystic ovary syndrome	0.0116	0.0312	CbGeAlD
Dorzolamide—CA4—pituitary gland—polycystic ovary syndrome	0.0113	0.0304	CbGeAlD
Dorzolamide—CA4—adipose tissue—polycystic ovary syndrome	0.0113	0.0302	CbGeAlD
Dorzolamide—CA1—endocrine gland—polycystic ovary syndrome	0.0112	0.0301	CbGeAlD
Dorzolamide—CA4—adrenal gland—polycystic ovary syndrome	0.0101	0.0271	CbGeAlD
Dorzolamide—CA4—female gonad—polycystic ovary syndrome	0.00945	0.0253	CbGeAlD
Dorzolamide—CA2—pituitary gland—polycystic ovary syndrome	0.00941	0.0252	CbGeAlD
Dorzolamide—CA2—adipose tissue—polycystic ovary syndrome	0.00937	0.0251	CbGeAlD
Dorzolamide—CA4—endocrine gland—polycystic ovary syndrome	0.00879	0.0235	CbGeAlD
Dorzolamide—CA2—adrenal gland—polycystic ovary syndrome	0.0084	0.0225	CbGeAlD
Dorzolamide—CA2—female gonad—polycystic ovary syndrome	0.00784	0.021	CbGeAlD
Dorzolamide—CA2—vagina—polycystic ovary syndrome	0.00779	0.0208	CbGeAlD
Dorzolamide—CA2—endocrine gland—polycystic ovary syndrome	0.00729	0.0195	CbGeAlD
Dorzolamide—Respiratory distress—Metformin—polycystic ovary syndrome	0.00725	0.093	CcSEcCtD
Dorzolamide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00617	0.0165	CbGeAlD
Dorzolamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0047	0.0126	CbGeAlD
Dorzolamide—Nasal congestion—Metformin—polycystic ovary syndrome	0.00367	0.0471	CcSEcCtD
Dorzolamide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00343	0.044	CcSEcCtD
Dorzolamide—Pain in extremity—Metformin—polycystic ovary syndrome	0.00334	0.0429	CcSEcCtD
Dorzolamide—Influenza—Metformin—polycystic ovary syndrome	0.00289	0.0371	CcSEcCtD
Dorzolamide—Angina pectoris—Metformin—polycystic ovary syndrome	0.00282	0.0361	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00269	0.0345	CcSEcCtD
Dorzolamide—Bradycardia—Metformin—polycystic ovary syndrome	0.00235	0.0302	CcSEcCtD
Dorzolamide—Erythema—Metformin—polycystic ovary syndrome	0.00201	0.0258	CcSEcCtD
Dorzolamide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00197	0.0253	CcSEcCtD
Dorzolamide—Vision blurred—Metformin—polycystic ovary syndrome	0.0019	0.0243	CcSEcCtD
Dorzolamide—Syncope—Metformin—polycystic ovary syndrome	0.00181	0.0232	CcSEcCtD
Dorzolamide—Palpitations—Metformin—polycystic ovary syndrome	0.00178	0.0228	CcSEcCtD
Dorzolamide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00177	0.0227	CcSEcCtD
Dorzolamide—Hypertension—Metformin—polycystic ovary syndrome	0.00174	0.0223	CcSEcCtD
Dorzolamide—Chest pain—Metformin—polycystic ovary syndrome	0.00171	0.022	CcSEcCtD
Dorzolamide—Discomfort—Metformin—polycystic ovary syndrome	0.00169	0.0217	CcSEcCtD
Dorzolamide—Oedema—Metformin—polycystic ovary syndrome	0.00164	0.0211	CcSEcCtD
Dorzolamide—Shock—Metformin—polycystic ovary syndrome	0.00162	0.0207	CcSEcCtD
Dorzolamide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00159	0.0204	CcSEcCtD
Dorzolamide—Anorexia—Metformin—polycystic ovary syndrome	0.00157	0.0201	CcSEcCtD
Dorzolamide—Hypotension—Metformin—polycystic ovary syndrome	0.00154	0.0197	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0015	0.0192	CcSEcCtD
Dorzolamide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00148	0.0189	CcSEcCtD
Dorzolamide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00147	0.0188	CcSEcCtD
Dorzolamide—Somnolence—Metformin—polycystic ovary syndrome	0.00146	0.0187	CcSEcCtD
Dorzolamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00145	0.0186	CcSEcCtD
Dorzolamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00143	0.0183	CcSEcCtD
Dorzolamide—Fatigue—Metformin—polycystic ovary syndrome	0.00142	0.0182	CcSEcCtD
Dorzolamide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00135	0.0174	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00134	0.0172	CcSEcCtD
Dorzolamide—Urticaria—Metformin—polycystic ovary syndrome	0.00131	0.0167	CcSEcCtD
Dorzolamide—Abdominal pain—Metformin—polycystic ovary syndrome	0.0013	0.0167	CcSEcCtD
Dorzolamide—Asthenia—Metformin—polycystic ovary syndrome	0.00118	0.0151	CcSEcCtD
Dorzolamide—Pruritus—Metformin—polycystic ovary syndrome	0.00116	0.0149	CcSEcCtD
Dorzolamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00112	0.0144	CcSEcCtD
Dorzolamide—Dizziness—Metformin—polycystic ovary syndrome	0.00109	0.0139	CcSEcCtD
Dorzolamide—Vomiting—Metformin—polycystic ovary syndrome	0.00104	0.0134	CcSEcCtD
Dorzolamide—Rash—Metformin—polycystic ovary syndrome	0.00104	0.0133	CcSEcCtD
Dorzolamide—Dermatitis—Metformin—polycystic ovary syndrome	0.00104	0.0133	CcSEcCtD
Dorzolamide—Headache—Metformin—polycystic ovary syndrome	0.00103	0.0132	CcSEcCtD
Dorzolamide—Nausea—Metformin—polycystic ovary syndrome	0.000976	0.0125	CcSEcCtD
Dorzolamide—CA14—Metabolism—TH—polycystic ovary syndrome	0.000789	0.00144	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—LHB—polycystic ovary syndrome	0.000785	0.00143	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000784	0.00143	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000781	0.00142	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000776	0.00141	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—TH—polycystic ovary syndrome	0.000769	0.0014	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—TH—polycystic ovary syndrome	0.000769	0.0014	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000769	0.0014	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000768	0.0014	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—SLC2A4—polycystic ovary syndrome	0.000768	0.0014	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000757	0.00138	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000748	0.00136	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000748	0.00136	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000744	0.00136	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000744	0.00136	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000741	0.00135	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000739	0.00135	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000729	0.00133	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000727	0.00132	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000722	0.00132	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP19A1—polycystic ovary syndrome	0.000722	0.00132	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—RRM2—polycystic ovary syndrome	0.000721	0.00131	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000718	0.00131	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—TH—polycystic ovary syndrome	0.000718	0.00131	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000714	0.0013	CbGpPWpGaD
Dorzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000713	0.0013	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000703	0.00128	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000703	0.00128	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000698	0.00127	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000698	0.00127	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—YAP1—polycystic ovary syndrome	0.000695	0.00127	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.000691	0.00126	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—LHB—polycystic ovary syndrome	0.000691	0.00126	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000684	0.00125	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000675	0.00123	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000674	0.00123	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000674	0.00123	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NAMPT—polycystic ovary syndrome	0.000668	0.00122	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.000666	0.00122	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—TH—polycystic ovary syndrome	0.000665	0.00121	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—RRM2—polycystic ovary syndrome	0.000663	0.00121	CbGpPWpGaD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000662	0.00121	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000659	0.0012	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000657	0.0012	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000657	0.0012	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000654	0.00119	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000647	0.00118	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GNAS—polycystic ovary syndrome	0.000644	0.00117	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.00064	0.00117	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—YAP1—polycystic ovary syndrome	0.000639	0.00116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000635	0.00116	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000632	0.00115	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GNAS—polycystic ovary syndrome	0.000628	0.00114	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GNAS—polycystic ovary syndrome	0.000628	0.00114	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000623	0.00114	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000614	0.00112	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NAMPT—polycystic ovary syndrome	0.000614	0.00112	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NCOR1—polycystic ovary syndrome	0.000614	0.00112	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000613	0.00112	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000608	0.00111	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000606	0.00111	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000602	0.0011	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	0.000598	0.00109	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NCOR1—polycystic ovary syndrome	0.000598	0.00109	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000597	0.00109	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000592	0.00108	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000588	0.00107	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GNAS—polycystic ovary syndrome	0.000586	0.00107	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GNAS—polycystic ovary syndrome	0.000586	0.00107	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000586	0.00107	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000585	0.00107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000584	0.00107	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000583	0.00106	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1A1—polycystic ovary syndrome	0.000582	0.00106	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000577	0.00105	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000572	0.00104	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	0.000567	0.00103	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000567	0.00103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000564	0.00103	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000563	0.00103	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000562	0.00102	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	0.000558	0.00102	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NCOR1—polycystic ovary syndrome	0.000558	0.00102	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000543	0.00099	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—MTHFR—polycystic ovary syndrome	0.000542	0.000989	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.00054	0.000984	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000539	0.000982	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000535	0.000976	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000533	0.000972	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—TH—polycystic ovary syndrome	0.00053	0.000967	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000529	0.000965	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000529	0.000965	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	0.000529	0.000964	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—MTHFR—polycystic ovary syndrome	0.000529	0.000964	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000525	0.000957	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000517	0.000943	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000517	0.000943	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000516	0.000941	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00051	0.000931	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—TH—polycystic ovary syndrome	0.000509	0.000927	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000503	0.000918	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000495	0.000903	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000495	0.000902	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	0.000493	0.0009	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	0.000493	0.0009	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.00049	0.000894	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000489	0.000891	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000488	0.000889	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—TH—polycystic ovary syndrome	0.000488	0.000889	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000485	0.000885	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000481	0.000877	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000474	0.000865	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000472	0.00086	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000465	0.000848	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000465	0.000848	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000457	0.000834	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000446	0.000813	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.00044	0.000802	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000437	0.000796	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000434	0.000791	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—POMC—polycystic ovary syndrome	0.000434	0.000791	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.000433	0.00079	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—INS—polycystic ovary syndrome	0.000431	0.000787	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—TH—polycystic ovary syndrome	0.000429	0.000782	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.000429	0.000782	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARG—polycystic ovary syndrome	0.000429	0.000782	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000425	0.000775	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—POMC—polycystic ovary syndrome	0.000423	0.000771	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000423	0.000771	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.00042	0.000767	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—INS—polycystic ovary syndrome	0.00042	0.000767	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000417	0.00076	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000415	0.000757	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000415	0.000757	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000413	0.000752	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.0004	0.00073	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.0004	0.00073	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GNAS—polycystic ovary syndrome	0.000398	0.000726	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000396	0.000722	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000395	0.000721	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.000395	0.00072	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.000395	0.00072	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.000392	0.000716	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—INS—polycystic ovary syndrome	0.000392	0.000716	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000392	0.000715	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000391	0.000713	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000387	0.000705	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000386	0.000704	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000381	0.000694	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000379	0.000692	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000379	0.000692	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NCOR1—polycystic ovary syndrome	0.000379	0.000691	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000375	0.000684	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000375	0.000683	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000371	0.000676	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000366	0.000667	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.000365	0.000665	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000364	0.000663	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000359	0.000655	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000353	0.000643	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000352	0.000641	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.00035	0.000638	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.00035	0.000637	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000345	0.000629	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—polycystic ovary syndrome	0.000335	0.000611	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000333	0.000608	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000322	0.000587	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000316	0.000576	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000311	0.000567	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000307	0.000559	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000305	0.000557	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.0003	0.000547	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.0003	0.000547	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000296	0.000539	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000295	0.000537	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000292	0.000532	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—INS—polycystic ovary syndrome	0.00029	0.000529	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000288	0.000526	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000284	0.000518	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000283	0.000517	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—POMC—polycystic ovary syndrome	0.00028	0.00051	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—INS—polycystic ovary syndrome	0.000278	0.000507	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000274	0.000499	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—polycystic ovary syndrome	0.000272	0.000496	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—POMC—polycystic ovary syndrome	0.000268	0.000489	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—INS—polycystic ovary syndrome	0.000267	0.000486	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000251	0.000458	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00025	0.000456	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00025	0.000456	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	0.000239	0.000436	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000238	0.000435	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—POMC—polycystic ovary syndrome	0.000236	0.00043	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—INS—polycystic ovary syndrome	0.000234	0.000427	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000233	0.000424	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000232	0.000423	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000227	0.000415	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000225	0.00041	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000203	0.000369	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000198	0.000361	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000198	0.000361	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000193	0.000352	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000191	0.000348	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000181	0.00033	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000176	0.000321	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000172	0.000314	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000167	0.000304	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000166	0.000302	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000157	0.000287	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000154	0.00028	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.00015	0.000273	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000149	0.000271	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000143	0.000261	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000138	0.000251	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000137	0.00025	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000136	0.000248	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000135	0.000246	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000134	0.000244	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000128	0.000234	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000127	0.000232	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000126	0.000231	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000116	0.000212	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000114	0.000207	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00011	0.000201	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000109	0.0002	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000106	0.000194	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000101	0.000185	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.0001	0.000182	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.81e-05	0.000179	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	9.45e-05	0.000172	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.08e-05	0.000166	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.97e-05	0.000164	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	8.93e-05	0.000163	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	8.51e-05	0.000155	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	8.47e-05	0.000154	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.34e-05	0.000152	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	8.07e-05	0.000147	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	7.52e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.22e-05	0.000132	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.02e-05	0.000128	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.6e-05	0.00012	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.1e-05	0.000111	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.01e-05	0.00011	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	5.98e-05	0.000109	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.89e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.61e-05	0.000102	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.32e-05	9.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.96e-05	9.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.02e-05	7.33e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.97e-05	7.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.94e-05	7.19e-05	CbGpPWpGaD
